The First People's Hospital of Hefei
Welcome,         Profile    Billing    Logout  
 3 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Huang, Jinhua
TALEM, NCT05555316: TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

Checkmark Data from P2 trial in combination with TACE in HCC at ASCO-GI 2023
Jan 2023 - Jan 2023: Data from P2 trial in combination with TACE in HCC at ASCO-GI 2023
Recruiting
2
46
RoW
TACE combined with Lenvatinib, lenvima
Sun Yat-sen University
Liver Tumor
01/23
11/23
NCT02964260: RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma

Recruiting
N/A
410
RoW
Chemotherapy drug, Chemotherapy, Embolic agents, Embolization, Simultaneously, Treatment interval, Sequentially, Ablation, RFA/MWA
Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong Provincial People's Hospital
Hepatocellular Carcinoma, Adult
12/22
12/22
NCT03783871: NeuWave HCC China Study

Completed
N/A
135
RoW
Microwave ablation
Ethicon, Inc.
Liver Tumor, Hepatocellular Carcinoma
01/24
01/24
NCT06265350: Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

Recruiting
N/A
80
RoW
Cadonilimab, Bevacizumab, Cryoablation
Sun Yat-sen University
Hepatocellular Carcinoma, Liver Cancer Stage IV, Pulmonary Metastases, Cadonilimab, Bevacizumab, Cryoablation
01/26
01/27
NCT06061276: bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Recruiting
N/A
40
RoW
bTAE-HAIC, Lenvatinib, TKI inhibits, Camrelizumab, programmed cell death protein-1 (PD-1) antibody
Sun Yat-sen University
Liver Diseases, Hepatocellular Carcinoma, Immunotherapy, Camrelizumab, Lenvatinib
06/25
12/25
NCT06070636: bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Recruiting
N/A
30
RoW
bTAE-HAIC, Lenvatinib, TKI inhibits, Sintilimab, programmed cell death protein-1 (PD-1) antibody
Sun Yat-sen University
Liver Diseases, Hepatocellular Carcinoma, Immunotherapy, Lenvatinib, Sintilimab
01/25
06/25
Dong, Zhou
PROTECT-2, NCT06134908: PRevention of OsTEoporotiC FracTure 2 Pilot Study

Recruiting
N/A
50
RoW
Multifaceted Intervention
Third Affiliated Hospital, Sun Yat-Sen University, Sir Run Run Shaw Hospital, The Second Affiliated Hospital of Hunan University of Chinese Medicine, Longgang Orthopedics Hospital of Shenzhen, The First People's Hospital of Hefei, Dongguan Eighth People's Hospital, The Third People's Hospital of Longgang District Shenzhen
Fragility Fracture
06/25
06/27

Download Options